PBAC's latest decision on Amino acid formula with vitamins and minerals (multiple formulations): Recommended with restriction (2021). Considered for Nutritional supplementation for patients from three years of age with disorders of protein metabolism (homocystinuria, phenylketonuria, maple syrup urine disease, and tyrosinaemia).
PBAC outcome
Recommended with restriction
Restricted
ICER (AUD/QALY)
Not modelled
no economic evaluation
Submissions
5
first 2021
Submissions
5
2021 → 2021
Eligible population
Patients from three years of age with disorders of protein metabolism (homocystinuria, phenylketonuria, maple syrup urine disease, tyrosinaemia) eligible for PBS subsidy.
Therapy area
Metabolic
Line of therapy
Not applicable
Evidence base
Other
Economic model
Not modelled
ICER note
Not modelled — this is a minor submission for formulation changes to existing PBS-listed products with no price changes and no economic evaluation.
Submission history
Jul 2021: Recommended with restriction · Restricted
Jul 2021: Recommended with restriction · Restricted
Jul 2021: Recommended with restriction · Restricted
Jul 2021: Recommended with restriction · Restricted
Jul 2021: Recommended with restriction · Restricted